Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Notification of holding of treasury shares
Zealand Pharma - Notification of holding of treasury shares
GlobeNewswire

Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

forbes.com - Tim Bajarin - Why AI-Driven Drug Discovery Is Becoming Pharma's Next Big Bet
Why AI-Driven Drug Discovery Is Becoming Pharma's Next Big Bet
Forbes

AI is not replacing scientific intuition but rather enhancing early-stage research. My first two years of college were in a special medical school program focused on the courses required to get into a pharmacy program, to become a pharmacist.

scmp.com - Vivian Au - Chinese tech, pharma firms eye Hong Kong as springboard for global expansion
Chinese tech, pharma firms eye Hong Kong as springboard for global expansion
South China Morning Post

Mainland Chinese technology and pharmaceutical companies are using Hong Kong as a launching pad for global expansion, industry leaders have said, as a major state-owned drugmaker weighs whether to invest in the city's Northern Metropolis…

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
GlobeNewswire

Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

seekingalpha.com - SA Transcripts - InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call Transcript
InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call Transcript
Seeking Alpha

InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call August 24, 2026 8:30 AM EDT Jisong Cui - Co-Founder, Chairwoman & CEO Xin Fu - Chief Financial Officer Renbin Zhao - Senior VP of Clinical Development & Medical Research and Executive Director…

newswire.ca - Groupe LSL PHARMA INC. - LSL PHARMA GROUP REPORTS RECORD REVENUES AND SECOND QUARTER 2026 RESULTS
LSL PHARMA GROUP REPORTS RECORD REVENUES AND SECOND QUARTER 2026 RESULTS
CNW

Record quarterly revenues from both the CMO and Private Label business segments; Results include the commercial launch of the new eye-drops portfolio; Health Canada Remediation plan and production capacity scale-up at Steri-Med progressing as…

smh.com.au - Kishor Napier-Raman - Big pharma's next $10 billion gamble: Ozempic for your brain
Big pharma's next $10 billion gamble: Ozempic for your brain
The Sydney Morning Herald

A new wave of treatments for a rare illness are being touted as the next major breakthrough from the same class of drugs as Ozempic, sparking multibillion-dollar acquisitions from pharmaceutical giants but caution from experts who warn that more…

thehindu.com - The Hindu Bureau - Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
The Hindu

Generic drugmaker Natco Pharma is investing an additional $14 million in U.S.-based biotechnology company eGenesis, which is developing genetically engineered, human-compatible organs for transplantation. The latest investment will be made through…

straitstimes.com - How big pharma targets obesity in China's weight-loss market
How big pharma targets obesity in China's weight-loss market
The Straits Times

SHANGHAI – Weight-loss drugmakers, vying to tighten the belts of Chinese consumers, are promoting obesity awareness in metro stations, exercise studios and soccer stadiums as local restrictions prevent the direct advertising of prescription…

thehindubusinessline.com - Natco Pharma to invest $14 million in eGenesis Inc
Natco Pharma to invest $14 million in eGenesis Inc
BusinessLine

Natco Pharma on Tuesday said it is investing $14 million (over ₹130 crore) in eGenesis Inc, a US-based biotechnology firm, through its two subsidiaries. As part of the transaction, Natco Pharma (Canada) Inc will invest $9.5 million and Natco…

marketbeat.com - Parkman Healthcare Partners LLC Acquires New Position in Urogen Pharma $URGN
Parkman Healthcare Partners LLC Acquires New Position in Urogen Pharma $URGN
MarketBeat

Parkman Healthcare Partners LLC acquired a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional…

marketbeat.com - NervGen Pharma (NASDAQ:NGEN) Given Average Recommendation of 'Moderate Buy' by Analysts
NervGen Pharma (NASDAQ:NGEN) Given Average Recommendation of 'Moderate Buy' by Analysts
MarketBeat

Shares of NervGen Pharma (NASDAQ:NGEN - Get Free Report) have earned a consensus rating of 'Moderate Buy' from the six brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell…

marketbeat.com - The Manufacturers Life Insurance Company Purchases New Stake in BridgeBio Pharma, Inc. $BBIO
The Manufacturers Life Insurance Company Purchases New Stake in BridgeBio Pharma, Inc. $BBIO
MarketBeat

The Manufacturers Life Insurance Company acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission…

swissinfo.ch - Aylin Elçi - Swiss non-profit drugmakers team up as funding shrinks
Swiss non-profit drugmakers team up as funding shrinks
www.swissinfo.ch

• Three Geneva-based non-profit drug developers are pooling resources for R&D, advocacy and communications. • Pharma R&D spending on neglected diseases fell from $824 million in 2018 to $623 million in 2024. • Experts are…

thehindubusinessline.com - CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
BusinessLine

The Central Bureau of Narcotics (CBN) under the finance ministry and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, on Monday signed an agreement to boost exports of pharma…

Receive a Daily briefing on Pharma Industry News

Get Started